Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.
Kim
A Y
AY
Massachusetts General Hospital, Boston, USA.
Chung
R T
RT
Polsky
B
B
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006678:HIV / Q000276:immunology*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D012307:Risk Factors
D000998:Antiviral Agents